Day: June 7, 2024

The US Food and Drug Administration (US FDA) has approved Moderna’s mRNA respiratory syncytial virus (RSV) vaccine for adults 60 and older. According to the FDA, it no longer sought the input of the agency’s independent vaccine advisory committee because it did not foresee any issues or controversial issues arising from its decision. The product,…